CD133 + liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma

Cancer Letters

Volumn 315, Issue 2, 2012, Pages 129-137

  Piao, Lian Shu ^a,b   Hur, Wonhee ^a   Kim, Taek Kyun ^c   Hong, Sung Woo ^a   Kim, Sung Woo ^a   Choi, Jung Eun ^a   Sung, Pil Soo ^a   Song, Myeong Joon ^a   Lee, Byeong Chel ^d   Hwang, Daehee ^c   Yoon, Seung Kew ^a  

^a The Catholic University of Korea   (South Korea)

^b DALIAN UNIVERSITY   (China)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer stem cell; CD133; Hepatocellular carcinoma; Microarray; Radioresistance

Indexed keywords

CD133 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; CANCER STEM CELL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; RADIOSENSITIVITY; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, CD; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICROARRAY ANALYSIS; NEOPLASTIC STEM CELLS; PEPTIDES; RADIATION TOLERANCE; REACTIVE OXYGEN SPECIES;

MUS MUSCULUS;

EID: 84355162060     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.10.012     Document Type: Article

References (35)

1. Block T.M., Mehta A.S., Fimmel C.J., Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003, 22:5093-5107.
2. Chetty C., Bhoopathi P., Rao J.S., Lakka S.S. Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells. Int. J. Cancer 2009, 124:2468-2477.
3. Fornace A.J. Mammalian genes induced by radiation; activation of genes associated with growth control. Annu. Rev. Genet. 1992, 26:507-526.
4. Maity A., Kao G.D., Muschel R.J., McKenna W.G. Potential molecular targets for manipulating the radiation response. Int. J. Radiat. Oncol. Biol. Phys. 1997, 37:639-653.
5. Wiskirchen J., Dittmann H., Kehlbach R., Vogel-Claussen J., Gebert R., Dohmen B.M., Schober W., Bares R., Rodemann H.P., Claussen C.D., Duda S.H. Rhenium-188 for inhibition of human aortic smooth muscle cell proliferation. Int. J. Radiat. Oncol. Biol. Phys. 2001, 49:809-815.
6. Nerenstone S.R., Ihde D.C., Friedman M.A. Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat. Rev. 1988, 15:1-31.
7. Lau W.Y., Lai E.C. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis. Int. 2008, 7:237-257.
8. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
9. Klein W.M., Wu B.P., Zhao S., Wu H., Klein-Szanto A.J., Tahan S.R. Increased expression of stem cell markers in malignant melanoma. Mod. Pathol. 2007, 20:102-107.
10. Ma Y.H., Mentlein R., Knerlich F., Kruse M.L., Mehdorn H.M., Held-Feindt J. Expression of stem cell markers in human astrocytomas of different WHO grades. J. Neurooncol. 2008, 86:31-45.
11. Song W., Li H., Tao K., Li R., Song Z., Zhao Q., Zhang F., Dou K. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma. Int. J. Clin. Pract. 2008, 62:1212-1218.
12. Weigmann A., Corbeil D., Hellwig A., Huttner W.B. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc. Natl. Acad. Sci. USA 1997, 94:12425-12430.
13. Miraglia S., Godfrey W., Yin A.H., Atkins K., Warnke R., Holden J.T., Bray R.A., Waller E.K., Buck D.W. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997, 90:5013-5021.
14. Yin A.H., Miraglia S., Zanjani E.D., Almeida-Porada G., Ogawa M., Leary A.G., Olweus J., Kearney J., Buck D.W. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997, 90:5002-5012.
15. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
16. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
17. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
18. Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65:10946-10951.
19. Ma S., Chan K.W., Hu L., Lee T.K., Wo J.Y., Ng I.O., Zheng B.J., Guan X.Y. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132:2542-2556.
20. Rountree C.B., Senadheera S., Mato J.M., Crooks G.M., Lu S.C. Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice. Hepatology 2008, 47:1288-1297.
21. + HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 2008, 27:1749-1758.
22. Dunning M.J., Smith M.L., Ritchie M.E., Tavare S. Beadarray: R classes and methods for Illumina bead-based data. Bioinformatics 2007, 23:2183-2184.
23. Du P., Kibbe W.A., Lin S.M. Lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008, 24:1547-1548.
24. Hwang D., Smith J.J., Leslie D.M., Weston A.D., Rust A.G., Ramsey S., de Atauri P., Siegel A.F., Bolouri H., Aitchison J.D., Hood L. A data integration methodology for systems biology: experimental verification. Proc. Natl. Acad. Sci. USA 2005, 102:17302-17307.
25. Huang da W., Sherman B.T., Tan Q., Collins J.R., Alvord W.G., Roayaei J., Stephens R., Baseler M.W., Lane H.C., Lempicki R.A. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol. 2007, 8:R183.
26. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
27. Diehn M., Cho R.W., Lobo N.A., Kalisky T., Dorie M.J., Kulp A.N., Qian D., Lam J.S., Ailles L.E., Wong M., Joshua B., Kaplan M.J., Wapnir I., Dirbas F.M., Somlo G., Garberoglio C., Paz B., Shen J., Lau S.K., Quake S.R., Brown J.M., Weissman I.L., Clarke M.F. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009, 458:780-783.
28. Chiou S.H., Kao C.L., Chen Y.W., Chien C.S., Hung S.C., Lo J.F., Chen Y.J., Ku H.H., Hsu M.T., Wong T.T. Identification of CD133-positive radioresistant cells in atypical teratoid/rhabdoid tumor. PLoS One 2008, 3:e2090.
29. Han W., He Y.Y. Requirement for metalloproteinase-dependent ERK and AKT activation in UVB-induced G1-S cell cycle progression of human keratinocytes. Photochem. Photobiol. 2009, 85:997-1003.
30. Mingo-Sion A.M., Marietta P.M., Koller E., Wolf D.M., Van Den Berg C.L. Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. Oncogene 2004, 23:596-604.
31. Liang J., Slingerland J.M. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2003, 2:339-345.
32. Toyokuni S. Novel aspects of oxidative stress-associated carcinogenesis. Antioxid. Redox Signal. 2006, 8:1373-1377.
33. Beier D., Hau P., Proescholdt M., Lohmeier A., Wischhusen J., Oefner P.J., Aigner L., Brawanski A., Bogdahn U., Beier C.P. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 2007, 67:4010-4015.
34. Zhang G., Njauw C.N., Park J.M., Naruse C., Asano M., Tsao H. EphA2 is an essential mediator of UV radiation-induced apoptosis. Cancer Res. 2008, 68:1691-1696.
35. Dong L., Qi N., Ge R.M., Cao C.L., Lan F., Shen L. Overexpression of CD133 promotes the phosphorylation of Erk in U87MG human glioblastoma cells. Neurosci. Lett. 2010, 484:210-214.